Propanc Biopharma, Inc. Common Stock (PPCB) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Propanc Biopharma, Inc. Common Stock (PPCB) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $4.87 (capex $4.87 ) from operating cash flow of $18.73K. Check Propanc Biopharma, Inc. Common Stock cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.87
Capex + Investments
Operating Cash Flow
$18.73K
USD
Capital Expenditures
$4.87
USD
Annual Cash Flow Reinvestment Rate for Propanc Biopharma, Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Propanc Biopharma, Inc. Common Stock. For live market cap and broader valuation context, see PPCB market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow